PMC:7228307 / 44921-45037 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"807","span":{"begin":61,"end":68},"obj":"Gene"},{"id":"825","span":{"begin":82,"end":105},"obj":"Disease"}],"attributes":[{"id":"A807","pred":"tao:has_database_id","subj":"807","obj":"Gene:2214"},{"id":"A825","pred":"tao:has_database_id","subj":"825","obj":"MESH:D006402"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T76","span":{"begin":82,"end":105},"obj":"Disease"}],"attributes":[{"id":"A76","pred":"mondo_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/MONDO_0005570"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T791","span":{"begin":61,"end":63},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-sample-PD-IDO

    {"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T219","span":{"begin":96,"end":105},"obj":"http://purl.obolibrary.org/obo/OGMS_0000045"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"807","span":{"begin":61,"end":68},"obj":"Gene"},{"id":"825","span":{"begin":82,"end":105},"obj":"Disease"}],"attributes":[{"id":"A807","pred":"pubann:denotes","subj":"807","obj":"Gene:2214"},{"id":"A825","pred":"pubann:denotes","subj":"825","obj":"MESH:D006402"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T259","span":{"begin":0,"end":116},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-sample-PD-MONDO

    {"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T32","span":{"begin":82,"end":105},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005570"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T259","span":{"begin":0,"end":116},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Roledumab Rhesus D IgG1 Afucosylated Selectively enhance FcγRIII interaction Hematological disorders Phase III"}